Enzymotec To Present At The Jefferies and Co. 2013 Global Healthcare Conference
Published: Nov 14, 2013
MIGDAL HA'EMEQ, Israel, Nov. 14, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that Dr. Ariel Katz, the Company's President and Chief Executive Officer, will be presenting at the Jefferies 2013 Global Healthcare Conference to be held on November 20-21, 2013 in London, UK.
Help employers find you! Check out all the jobs and post your resume.